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Abstract Proteins with a bric-a'-brac, tramtrack, broad-com-
plex/Poxvirus zinc fingers (BTB/POZ) domain are implicated in
a broad variety of biological processes, including DNA binding,
regulation of gene transcription and organization of macro-
molecular structures. Kelch domain containing BTB/POZ
proteins like Mayven and Keap1 display limited sequence
similarity with the actin-fragmin kinase from Physarum, a
protein kinase with a kelch domain. We show that mouse
Keap1, a Caenorhabditis elegans protein that we named CKR,
and human Mayven bind 5P-p-fluorosulfonyl-benzoyl-adenosine
(FSBA), a covalently modifying ATP analogue. Binding with 2-
azido-ATP or ATP-Sepharose is also demonstrated. In contrast
to Mayven, FSBA binding by CKR and Keap1 was specifically
inhibited by excess ATP. The ATP binding pocket is located in
the N-terminal half of Keap1. Our findings indicate that several,
but not all, BTB/POZ-kelch domain proteins possess an
inconspicuous ATP binding cassette. ß 2002 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
BTB/POZ domains (bric-a'-brac, tramtrack, broad-complex/
Poxvirus zinc ¢ngers) [1,2] are found in actin binding proteins
as well as nuclear DNA binding proteins. Members of this
family are implicated in the regulation of subcellular localiza-
tion, DNA binding and gene expression by formation of het-
ero- or homomeric complexes (reviewed in [3]). The crystal
structure of the PLZF (promyelocytic leukemia zinc ¢nger)
BTB/POZ domain has been determined [4]. The complex is
shown to be a very tight homodimer with an extensive hydro-
phobic dimerization interface.
Several members of the heterogeneous kelch superfamily
contain a BTB/POZ domain in their amino-terminal domain
(reviewed in [5]). In the Drosophila kelch protein, the BTB/
POZ domain is essential for development of the egg chamber
ring canals. The amino-terminal BTB/POZ domain enables
dimerization of two kelch monomers: the actin binding ca-
pacity of the carboxy-terminal kelch repeat can then be used
for bundling and stabilizing actin ¢laments at the inner rim of
the canals [6]. The 28 members of the kelch superfamily are
characterized by the presence of four to seven repeats of a
V50 amino acid stretch, with eight characteristic signature
residues [5]. Based on the crystal structure of the kelch related
protein galactose oxidase from Dactylium dendroides [7] and
sequence similarity [5], the same L-propeller superfold is pre-
dicted for all other kelch repeat domains. Viral neuramini-
dases [8^10], heterotrimeric G-protein L-subunits [11] and
WD repeat containing proteins in general [12] all show a
similar L-propeller superfold.
Actin-fragmin kinase (AFK) of the slime mold Physarum
polycephalum also contains a kelch domain [13]. This protein
kinase phosphorylates actin on Thr203 [14] when one of the
fragmin isoforms (P, A or 60) binds actin in a 1:1 complex
[14^17]. Comparison between the catalytic subunits of PKA
[18] and AFK [19] showed conservation of barely ¢ve residues
in the core of AFK. These residues are involved in phosphoryl
transfer. Apart from this strict conservation, the AFK cata-
lytic domain shows no similarity with other protein kinases.
Detailed analysis of the similarities between AFK and kelch
related proteins pointed out a weak but extended sequence
similarity with the amino-terminal half of the BTB/POZ do-
main containing proteins Mayven (human), Keap1 (mouse)
and Caenorhabditis elegans yk103a10. Based on this limited
homology, we set out to investigate if the C. elegans protein
(CKR), Mayven or Keap1 share biological properties with the
AFK.
2. Materials and methods
Glutathione-Sepharose 4B, secondary HRP conjugated antibodies,
and Hybond C nitrocellulose membrane were purchased from Amer-
sham Pharmacia Biotech (Uppsala, Sweden). NBT/BCIP and GAR
alkaline phosphatase conjugated IgG were from Duchefa (Haarlem,
the Netherlands) and from Sigma (St. Louis, MO, USA), respectively.
Easy start tubes and the QuickChange mutagenesis kit were from
Molecular Bio-Products (San Diego, CA, USA) and Stratagene (La
Jolla, CA, USA), respectively. Platinum Taq and lipofectamine were
from Gibco BRL Life Technologies (Rockville, MD, USA). Com-
plete0 inhibitor cocktail tablets were from Boehringer Mannheim
(Mannheim, Germany). FSBA, NTPs, GTP-Sepharose and ATP-
Sepharose were purchased from Sigma. 2-Azido-[32P]ATP was from
ICN (Costa Mesa, CA, USA).
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2.1. cDNA cloning
2.1.1. CKR. The 5P side of the T27e9.4 cosmid contains three
ATG codons. Separate PCR reactions were performed on 1 Wg of a
yeast two-hybrid cDNA library from C. elegans adults (a kind gift of
Dr. Ir. Wim Van Crieckinge, DevGen, Gent, Belgium) according to
the following schedule: 3 min denaturation, 1 min denaturation at
94‡C, 1 min annealing at 60‡C, and extension for 30 s at 72‡C (2.5
units Platinum Taq DNA polymerase, 0.4 WM primers, 30 cycles).
Only the primer combination 5P-GGATCCCGGCATTCTCAATGT-
TCGCATCTG-3P (corresponding with the third ATG codon) and 5P-
GCGGCCGCTCACACATATGAGGTGGC-ATCGG-3P resulted in
a V1.8 kb cDNA.
The cDNA clone yk103a10 encoding CKR was also obtained by in
vivo excision from a Lambda ZAP II phagemid (obtained from Dr.
Yuji Kohara, National institute of Genetics, Japan) according to in-
structions of the manufacturer. The cDNA obtained from di¡erent
sources were both sequenced and showed complete sequence identity.
2.1.2. Keap1. Keap1 cDNA was ampli¢ed by PCR using a mouse
brain cDNA library as template (a kind gift of Dr. Bart Destrooper,
KUL) using the primers 5P-GGAATTCATGCAGCCCGAACCCAA-
GCTTAGCGG-3P and 5P-GCTCGAGTTTATTAGCAGGTACAG-
TTTTGTTGATC-3P. 25 cycles were performed with 2.5 units of Plat-
inum Taq (94‡C, 1 min; Tan : 62‡C, 1 min; Text : 72‡C, 1 min) yielding
a product of about 1.8 kb. The PCR fragment was cloned as an
EcoRI/XhoI fragment into pGEX-5X-1 (Amersham Pharmacia Bio-
tech).
The amino-terminal half of Keap1 (amino acids 1^340) was cloned
separately into pGEX-5X-1.
2.1.3. Mayven. The cDNA coding for Mayven was ampli¢ed by
PCR from a human ¢brosarcoma cDNA library (2fTGH cells; library
constructed by Els Pattyn, Department of Biochemistry, Faculty of
Medicine and Health Sciences, Ghent University, Belgium). The prim-
ers used were 5P-GGAATTCATGGAGACGCCGCCGCTGCCTCC-
CG-3P and 5P-AGCGGCCGCCTAATGGTTTATCAATAACTGTG-
ACC-CCTG-3P. The 1.5 kb cDNA was cloned into pGEX-5X-1.
2.2. Puri¢cation of recombinant GST fusion proteins
An overnight culture (250 ml Luria-Bertani broth (LB), 100 Wg/ml
ampicilin) of Escherichia coli MC1061 cells containing the pGEX-5X-
1 plasmids coding for CKR, Keap1 or Mayven was used to inoculate
a culture of 5 l. Cells were grown until OD595nm = 0.8 was reached;
expression was induced with 0.5 mM IPTG (Eurogentec, Seraing,
Belgium) and the cells were incubated for 20 h at 22‡C. After centri-
fugation at 3000Ug for 5 min, pellets were resuspended in ice-cold
lysis bu¡er (20 mM Tris pH 7.5, 150 mM NaCl, 1 mM phenylmeth-
ylsulfonyl £uoride (PMSF) and Complete1 protease inhibitor cocktail
tablets). Lysis was performed by passing the cells twice through a
French press (AMINCO, Illinois, USA). For optimal extraction, Tri-
ton X-100 was added to the supernatant to a ¢nal concentration
of 1%. The lysate was centrifuged for 1 h at 100 000Ug (4‡C). Puri-
¢cation on glutathione-Sepharose was performed according to in-
structions of the manufacturer, and appropriate fractions were
concentrated using a SpeedVac concentrator (Savant Instruments,
Holbrook, NY, USA). To remove impurities, proteins were further
puri¢ed to near homogeneity on a Superdex 200 gel ¢ltration column
(Amersham Pharmacia Biotech) equilibrated in 10 mM HEPES pH
7.4, 25 mM NaCl and 0.02% sodium azide at a £ow rate of 0.3 ml/
min.
2.3. FSBA binding assays
1 Wg protein was incubated with 0.5 mM 5P-p-£uorosulfonyl-benzo-
yl-adenosine (FSBA) in a total volume of 25 Wl in the presence of
5 mM MgCl2 and 100 mM HEPES, pH 7.2 (to avoid a drop in pH
when ATP was added at elevated concentrations). In competition
experiments ATP or other nucleotides were included. Reactions
were terminated by the addition of 5U Laemmli sample bu¡er [20].
Samples were analyzed by sodium dodecyl sulfate^polyacrylamide gel
electrophoresis (SDS^PAGE) and blotted onto nitrocellulose mem-
branes. BSA depleted anti-FSBA antibodies (generously donated by
Dr. M. Wymann, Institute of Biochemistry, University of Fribourg,
Fribourg, Switzerland) were added at a 1:2000 dilution, and binding
Fig. 1. Alignment between AFK (N-terminal half) and BTB/POZ-kelch proteins (N-terminal half). Pp, P. polycephalum ; Ce, C. elegans ; Hs,
Homo sapiens ; Mm, Mus musculus. Amino acids that are conserved in all four proteins are shown in red, amino acids that are conserved in
two or three members are depicted in blue. The shaded region is the BTB/POZ domain.
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was visualized following incubation with secondary anti-rabbit HRP
coupled antibodies and ECL detection reagents.
2.4. ATP-Sepharose binding assays
3 Wg CKR was incubated with 10 Wl settled GTP-Sepharose or
ATP-Sepharose in 10 mM HEPES pH 7, 50 mM KCl, 10 mM MgCl2,
1 mM DTT and 0.2% Triton X-100 overnight at 4‡C in a total volume
of 300 Wl. Following three washes with the same bu¡er, the pellet was
boiled in Laemmli sample bu¡er and analyzed by SDS^PAGE, fol-
lowed by Coomassie staining or Western blotting with anti-GST anti-
bodies.
2.5. Immunoprecipitation of GFP-Keap1
The Keap1 cDNA was cloned into pEGFP-N1 (Clontech) as an
EcoRI/BamHI fragment. MDCK-AZ cells [21] were transfected with
GFP tagged Keap1 or GFP (control) using lipofectamine. For immu-
noprecipitation, cells were washed twice with ice-cold TBS (20 mM
Tris, 150 mM NaCl, pH 7.4) and lysed in 20 mM Tris pH 7.4, 150
mM NaCl, 1 mM PMSF, 1 mM sodium orthovanadate, 10 mM NaF,
1 mM sodium pyrophosphate, 5 mM levamisole, 8 mM L-glycero-
phosphate and Complete1 protease inhibitor cocktail tablets, 1%
Triton X-100 and 0.5% NP40. Cells were disrupted by sonication in
a Vibra Cell W tip sonicator (Sonics and Materials Inc., Danbury,
CT, USA) set at 40% duty cycle. The extract was centrifuged
20 000Ug at 4‡C for 15 min. Following overnight incubation of anti-
bodies and cell lysate at 4‡C, beads were recovered by centrifugation
and the pellet was washed three times with ice-cold TBS supplemented
with 1% Triton X-100 and 0.5% NP40 and once with TBS without
detergents. SDS sample bu¡er was added and samples were boiled for
5 min followed by SDS^PAGE analysis and Coomassie staining.
2.6. Miscellaneous
Protein concentrations were determined by the method of Bradford
[22] using bovine serum albumin as standard. SDS^PAGE was carried
out according to [23]. Western blot analysis was performed as de-
scribed by Towbin et al. [24]. Total lab software for quantitation of
autoradiograms was from Phoretix (Newcastle upon Tyne, UK). Mul-
tiple sequence alignments were performed using the Multalin Program
(http://prodes.toulouse.inra.fr/multalin/multalin.html) [25].
3. Results and discussion
3.1. Database screening for AFK homologs
Available protein and DNA databases were screened with
the blastp algorithm [26] to search for homologs of the
P. polycephalum AFK. The C. elegans wormpep database
(http://www.sanger.ac.uk) yielded a predicted protein that re-
vealed similarity to both the carboxy-terminal (23% identity,
38% positives in a 130 amino acid stretch) and amino-terminal
domains of AFK (22% identity, 47% positives on a 44 amino
acid stretch). AFK residues K98 and E106, known to be in-
volved in ATP binding [19], were conserved in the C. elegans
protein (Fig. 1). Similar entries in human, mouse and rat se-
quence databases were found and these proteins include a
BTB/POZ domain in the N-terminal half and a C-terminal
kelch domain: they include the human Mayven protein [27],
mouse and rat Keap1 [28], and the predicted human genes
KIAA1490 and KIAA1687.
3.2. Puri¢cation of CKR, Mayven and Keap1
The three kelch domain containing proteins were expressed
in E. coli as fusion proteins with glutathione-S-transferase and
puri¢ed by a⁄nity chromatography (Fig. 2). Expression in
insect cells produced extremely low yields. Subsequent Super-
dex 200 gel ¢ltration analysis was performed to remove im-
purities, revealing that all three proteins form oligomers (not
shown) because they eluted at a molecular mass far above
their expected molecular mass as a monomer (Keap1: 68
kDa, Mayven: 65 kDa and CKR: 65 kDa). Homo-multime-
rizing properties and similar elution pro¢les on gel ¢ltration
chromatography have been described previously for the BTB/
POZ domain containing proteins calicin and the GAGA tran-
scription factor [29,30].
Fig. 2. Puri¢cation of kelch domain containing BTB/POZ proteins.
SDS^PAGE (10%) analysis of puri¢ed GST fusion proteins (arrow-
heads). C. elegans kelch related protein (lane 2), Keap1 (lane 3) and
Mayven (lane 4) were puri¢ed by additional gel ¢ltration chroma-
tography. Molecular mass markers are shown on the left. The gel
was stained with Coomassie brilliant blue.
Fig. 3. BTB/POZ-kelch domain proteins bind FSBA and are re-
tained by ATP-Sepharose. A: Proteins (0.5 WM) were incubated
with FSBA (0.5 mM) for the indicated periods of time, subjected to
SDS^PAGE and Western blotted with anti-FSBA antibodies. a,
AFK; b, CKR; c, Keap1; d, Mayven. 3, no addition of FSBA.
Note that Mayven shows no time dependent increase in FSBA bind-
ing. B: CKR was incubated with Sepharose (lane 1), GTP-Sepha-
rose (lane 2), ATP-Sepharose in the presence of 1 mM free ATP
(lane 3) or with ATP-Sepharose (lane 4). Left panel, Coomassie
staining; right panel, Western blot with GST antibodies. The full
length protein is indicated as well as the CKR breakdown product
(arrowhead).
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3.3. Binding of FSBA by CKR, Mayven and Keap1 is competed
speci¢cally by ATP
A minimal requirement for conventional protein kinases
and other nucleotide binding proteins is that they bind
ATP. Because the amount of recombinant protein obtained
was insu⁄cient for studies using £uorescent MANT-ATP
binding, we employed FSBA, a covalently modifying ATP
analog, that has been used extensively to study ATP binding
by a variety of proteins such as lipid kinases [31], 5P-lipoxy-
genase [32], isocitrate dehydrogenase kinase/phosphatase [33]
and the nuclear protein CHL1 [34]. Binding of FSBA was
monitored by Western blotting using anti-FSBA antibodies
previously employed to study PI3K [31].
Control experiments with recombinant AFK showed that
incubation with a constant amount of FSBA resulted in a
time dependent binding of the nucleotide analog (Fig. 3A,
a). Similar experiments with the BTB/BOZ-kelch domain con-
taining proteins showed that CKR and Keap1 also bound
FSBA in a time dependent manner (Fig. 3A, b and c). On
the other hand, Mayven showed binding kinetics di¡erent
from CKR and Keap1 (Fig. 3A, d) and this pattern was
similar to non-speci¢c binding of FSBA by serum albumin
(not shown).
Incubation of CKR with ATP-Sepharose or GTP-Sepha-
rose showed speci¢c retention of the protein onto ATP-Seph-
arose (Fig. 3B, left panel, lane 4), although some degradation
had occurred during incubation. No binding was observed
when free ATP was included in the mixture (Fig. 3B, left
panel, lane 3). Western blotting with GST antibodies con-
¢rmed the identity of CKR (Fig. 3B, right panel). A similar
pattern was obtained with Keap1 (not shown).
To investigate the binding speci¢city we performed compe-
tition experiments between FSBA and ATP. Since FSBA is a
covalently modifying ATP analog, incubation periods were
kept short (5 min) to avoid saturation by FSBA. When mix-
tures of FSBA and ATP were added to the AFK we observed
ATP mediated concentration dependent inhibition of FSBA
binding (Fig. 4A, a). This is in agreement with the presence of
an ATP binding site in the N-terminal catalytic domain of
AFK [19]. An equimolar ratio of FSBA and ATP resulted
inV50% inhibition of FSBA binding whereas a 20-fold molar
excess of ATP caused V90% inhibition. FSBA binding by
CKR and Keap1 was equally inhibited by increasing ATP
concentrations: 10 mM ATP caused V90% inhibition for
CKR and V75% inhibition for Keap1 (Fig. 4A, b and c).
Fig. 4. Competition experiments between ATP and FSBA, and nu-
cleotide speci¢city. A: 0.5 WM protein was incubated with 0.5 mM
FSBA with or without increasing ATP concentrations. (a) AFK =
positive control. Increasing ATP concentrations inhibit FSBA bind-
ing by CKR (b) and Keap1 (c). For (d) Mayven, excess ATP has
no inhibitory e¡ect. (e) Time course of FSBA binding by the Keap1
K61R mutant. 3, no addition of FSBA; +, addition of FSBA only.
B: Nucleotide speci¢city of BTB/POZ proteins. Competition be-
tween FSBA and (a) ATP, ADP or AMP for binding to Keap1 or
(b) ATP, CTP, GTP or TTP for binding to AFK, CKR or Keap1.
Nucleotides were used at a 20-fold molar excess in (a) and 10-fold
molar excess in (b). The inhibitory e¡ect is more pronounced for
ATP. +, FSBA without addition of nucleotide.
Fig. 5. The Keap1 N-terminal half binds ATP. Time dependent in-
cubation (a and b) and ATP/FSBA competition experiment (c) with
recombinant amino-terminal half of Keap1 (NtKeap1) demonstrate
that ATP binding properties of the N-terminal half are similar to
those of the entire protein. (a) shows FSBA binding of NtKeap1,
revealed with anti-FSBA antiserum; (b) shows time dependent asso-
ciation of NtKeap1 with 2-azido-[32P]ATP. (c) was developed as (a).
AFK was included as a positive control. 3, no FSBA. The arrow-
head shows NtKeap1. The protein above NtKeap1 was identi¢ed as
E. coli DNA K and co-puri¢ed with NtKeap1.
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However, FSBA binding to Mayven was not inhibited, even
at the highest ATP concentrations (Fig. 4A, d). Since binding
of FSBA by serum albumin is not inhibited by ATP either
(not shown), we deduce that Mayven associates with FSBA
and ATP in a non-speci¢c manner. On the other hand, the
inhibitory e¡ect of ATP on covalent modi¢cation of CKR
and Keap1 indicates that they bind ATP speci¢cally.
Amino acids that are conserved in the amino-terminal half
of AFK, Keap1 and CKR include residues Lys98 and Glu106.
K98 is involved in orienting the K-phosphate group of ATP,
and forms an additional salt bridge with E106. To investigate
the e¡ect of these amino acids on ATP binding, the corre-
sponding amino acids in Keap1 (K61R and E69A) and
CKR (K35R, K36R and E43G) were substituted. However,
all mutants bound FSBA with similar kinetics (shown for the
K61R mutant of Keap1, in Fig. 4A, e) as the wild type pro-
teins. We subsequently investigated whether the mutations
a¡ect putative enzymatic properties of the kelch related pro-
teins. However, (auto)phosphorylation or ATPase activity
could not be demonstrated. ATP binding had also no e¡ect
on oligomerization (not shown).
3.3.1. Inhibitory e¡ect of other nucleotides on FSBA binding
by BTB/POZ proteins. Competition assays further showed
that adenosine monophosphate (AMP) and adenosine diphos-
phate (ADP) were less e¡ective than ATP in blocking FSBA
modi¢cation of Keap1 (Fig. 4B, a). To further test the nucle-
otide binding speci¢city of BTB/POZ proteins, comparative
experiments were performed with ATP, GTP, CTP and
TTP. All were used at 10-fold molar excess to FSBA. In
each case, ATP showed stronger inhibitory activity towards
FSBA binding than the other nucleotides (Fig. 4B, b^d).
From these experiments we conclude that CKR and Keap1
display the highest a⁄nity for ATP.
3.3.2. The N-terminal half of Keap1 binds ATP. To estab-
lish whether the amino-terminal half of Keap1 (amino acids
1^340, containing the BTB/POZ domain) is necessary and
su⁄cient for ATP binding, we expressed and puri¢ed this
construct separately. Incubation with FSBA showed a time
Fig. 6. Keap1 does not co-localize with ¢lamentous actin. A: Detection of GFP-Keap1. Lane 1, control: detection of GFP following immuno-
precipitation from transiently transfected MDCK-AZ cells and Western blotting with anti-GFP antibodies. GFP is indicated by the arrow.
Lane 2, the same experiment as in lane 1 but with MDCK-AZ cells transfected with GFP tagged Keap1. B^E. Immuno£uorescence images of
MDCK-AZ cells transiently transfected with GFP-Keap1 (C) or GFP control (E) and stained for F-actin with TRITC-phalloidin (B, D). GFP-
Keap1 is di¡usely distributed throughout the cytosol; GFP stains the nucleus and cytosol.
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dependent increase in binding (Fig. 5a) as revealed with the
FSBA antiserum. In addition, crosslinking of NtKeap1 with
5 WM 2-azido-[32P]ATP also showed an increase in binding
over time (Fig. 5b). ATP mediated inhibition of FSBA bind-
ing (Fig. 5c) was similar to what was found for the full length
protein. This result illustrates that intrinsic ATP binding ac-
tivity resides in the N-terminal half of the protein.
3.4. Keap1 is a cytosolic protein that does not interact with
actin
Actin binding has been demonstrated for the kelch domains
of the Drosophila kelch protein [6], scruin [35^38], ENC-1 [39],
Mayven [27] and calicin [29]. Based on these ¢ndings, there is
a tendency to assume that all kelch domains bind actin. We
tested this hypothesis for Keap1.
Identi¢cation of Keap1 binding partners was pursued by
co-immunoprecipitation of GFP-Keap1 from transfected
MDCK cells. Immunoprecipitation of GFP-Keap1 using
anti-GFP antibodies followed by Western blotting with anti-
actin antibodies did not show co-immunoprecipitation with
actin (data not shown). Probing the blot with anti-GFP anti-
bodies revealed a protein of approximately 100 kDa showing
that the fusion protein was expressed (Fig. 6A, lane 2). GFP-
Keap1 transfected MDCK cells showed a di¡use cytoplasmic
staining of the fusion protein (Fig. 6C) with no apparent co-
localization with actin stress ¢bers or cortical F-actin and this
was con¢rmed by superposition of the staining patterns (not
shown). We therefore conclude that the Keap1 kelch domain,
in contrast to several other kelch domains such as Mayven
[27] or Drosophila kelch [6], does not bind actin under the
conditions studied here. We do not exclude however that,
under altered conditions, Keap1 could associate with actin.
This is the ¢rst report showing that kelch proteins with a
BTB/POZ domain contain a cryptic nucleotide binding cas-
sette speci¢c for ATP. Our results suggest that only selected
BTB/POZ-kelch proteins are characterized by this property
since Mayven was shown to bind FSBA in a non-speci¢c
manner. At present, it is not clear which residues in the N-
terminal half of Keap1 or CKR might be responsible for
selective nucleotide binding. A very conserved ATP binding
motif is the Rossman fold, but analysis of the PLZF BTB/
POZ domain crystal structure [4] does not show a typical
beta-alpha-beta-alpha-beta structure, characteristic of ATP
binding proteins. ATP binding is not associated with intrinsic
(auto)phosphorylation or ATPase activity of the BTB/POZ-
kelch proteins that were tested. We cannot exclude at this
stage that a co-factor of BTB/POZ-kelch proteins could trig-
ger ATPase activity. Alternatively, ATP binding might a¡ect
the stability of the protein or its interaction with ligands.
In conclusion, the observation that BTB/POZ proteins con-
tain a nucleotide binding pocket adds a new element to this
¢eld of research and opens interesting new prospects for
studying the biology of this extended class of proteins and
their pleiotropic e¡ects on the regulation of gene expression.
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